Imunon
IMNN
14 hedge funds and large institutions have $442K invested in Imunon in 2024 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 0 reducing their positions, and 3 closing their positions.
0.03% more ownership
Funds ownership: 0.27% → 0.3% (+0.03%)
7% less funds holding
Funds holding: 15 → 14 (-1)
18% less capital invested
Capital invested by funds: $539K → $442K (-$97.4K)
33% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$17.5K |
| 2 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.9K |
| 3 |
State Street
Boston,
Massachusetts
|
+$9.43K |
| 4 |
Renaissance Technologies
New York
|
+$7.43K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$5.44K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$238 |
| 2 |
Wells Fargo
San Francisco,
California
|
-$120 |
| 3 |
Citigroup
New York
|
-$75 |
IMNN Hedge Fund Activity: Q2 2024 in Review
14 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q2 2024, worth a combined $442K — down 18% from $539K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of IMNN and 2 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 5 added.
The largest buyer was UBS Group, adding an estimated $17.5K. The largest seller was Fidelity Investments, exiting entirely with an estimated $238 sold.
- 14 institutional investors held Imunon (IMNN) as of Q2 2024, down from 15 in Q1 2024.
- Funds reported $442K of Imunon stock for Q2 2024, down 18% quarter-over-quarter.
- 2 funds opened new Imunon positions in Q2 2024 and 3 closed out, a net change of -1 holder.
- The largest Imunon buyer in Q2 2024 was UBS Group, an estimated $17.5K added.
- The largest Imunon seller in Q2 2024 was Fidelity Investments, an estimated $238 sold.
Based on aggregated 13F filings for Q2 2024.